Clinical Decision Support for Diabetes Management
This study is looking at how an electronic medical record tool, called Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support (GlucAlert-CDS), affects blood sugar (dysglycemia) in hospitalized patients. It also wants to see if this tool improves patient outcomes and saves money, and what healthcare providers think of it. You could be eligible if you are an adult (over 18) patient hospitalized or receiving outpatient care at Penn State Health, Hershey Medical Center, St. Joseph's Hospital, Hampden Medical Center, Holy Spirit Medical Center, and Lancaster Medical Center. The study will be successful if it shows that the tool helps reduce how long patients stay in the hospital. The current status of this study is unclear.
- Study design
- This study plans to include 15,732 participants. It will involve 12 alternating phases, each lasting 3 months, over a total of 36 months.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your hospital length of stay will be measured for up to 3 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Diabetes Clinical Decision Support
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Ariana Pichardo-Lowden, MD · PRINCIPAL_INVESTIGATOR · Penn State College of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Average hospital length of stay (LOS)Duration of hospital admission, up to 3 months
Number of days in the hospital